USP releases Medicare Rx model guidelines

February 13, 2006

The USP has submitted to CMS its Medicare Rx drug benefit model guidelines that Part D drug plans can use for formulary development during the 2007 benefit year. Version 2.0 of the guidelines reduced the number of unique drug categories and classes from 146 to 133 and increased the formulary key drug types from 118 to 141.

USP releases Medicare Rx model guidelines

The USP has submitted to CMS its Medicare Rx drug benefit model guidelines that Part D drug plans can use for formulary development during the 2007 benefit year. Version 2.0 of the guidelines reduced the number of unique drug categories and classes from 146 to 133 and increased the formulary key drug types from 118 to 141. The revision process will be ongoing to allow greater involvement by stakeholders, according to USP. To access the model guidelines and track the revisions, go to http://www.usp.org/healthcareInfo/mmg/phase2/.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.